<p>Bosentan and macitentan treatment resulted in a dose-dependent reduction in total accumulation of d<sub>8</sub>-TCA. Ambrisentan, bosentan and macitentan treatment each resulted in a dose-dependent reduction in cellular accumulation of d<sub>8</sub>-TCA. Data presented as mean (±SD) expressed as percent of control treated; n = 3 donors; *P<0.05 bosentan vs. control; # P<0.05 macitentan vs. control.</p
<p>(a) Cells were incubated with the indicated concentrations of taurocholate for 1 hour. No release...
<p>(A) Dose-response analysis of T-3764518 in HCT-116 cells treated with serial dilutions of T-37645...
<p>(A-D) Inhibitory effects of telmisartan, but not candesartan, on TPA-induced cell proliferation i...
<p>Ambrisentan displayed the lowest intracellular accumulation followed by bosentan, sitaxsentan, an...
<p>(A) HepaRG cells were treated with 1 µM of <sup>3</sup>H-TC for 300 sec at 4, 24 and 96 h after s...
<p>ERAs were evaluated either in the absence or presence of the transporter inhibitors rifampicin (4...
a<p>Data presented as mean ± standard deviation for 3 independent studies performed in duplicate;</p...
Inhibition of the transporter-mediated hepatobiliary elimination of bile salts is a putative mechani...
Previous reports have indicated that in vitro biliary clearance (Clbiliary) determined in sandwich-c...
<p>(A) HepaRG cells were treated with 1 µM of <sup>3</sup>H-TC for 300 sec at 4, 24 and 96 h after s...
Abstract: Tolvaptan is a selective V 2 -receptor antagonist primarily metabolized by CYP3A. The pres...
<p>Confluent Caco-2 cells were incubated for 24 hrs with 0, 4, 8, 12 and 24 µg of toxin B in the pre...
Hepatocellular accumulation of bile acids due to inhibition of the canalicular bile salt export pump...
Tolvaptan is a selective V2-receptor antagonist primarily metabolized by CYP 3A. The present study i...
<p>MiaPaCa-2 and SOJ-6 cells were incubated 1h with drugs affecting lipid metabolism at the indicate...
<p>(a) Cells were incubated with the indicated concentrations of taurocholate for 1 hour. No release...
<p>(A) Dose-response analysis of T-3764518 in HCT-116 cells treated with serial dilutions of T-37645...
<p>(A-D) Inhibitory effects of telmisartan, but not candesartan, on TPA-induced cell proliferation i...
<p>Ambrisentan displayed the lowest intracellular accumulation followed by bosentan, sitaxsentan, an...
<p>(A) HepaRG cells were treated with 1 µM of <sup>3</sup>H-TC for 300 sec at 4, 24 and 96 h after s...
<p>ERAs were evaluated either in the absence or presence of the transporter inhibitors rifampicin (4...
a<p>Data presented as mean ± standard deviation for 3 independent studies performed in duplicate;</p...
Inhibition of the transporter-mediated hepatobiliary elimination of bile salts is a putative mechani...
Previous reports have indicated that in vitro biliary clearance (Clbiliary) determined in sandwich-c...
<p>(A) HepaRG cells were treated with 1 µM of <sup>3</sup>H-TC for 300 sec at 4, 24 and 96 h after s...
Abstract: Tolvaptan is a selective V 2 -receptor antagonist primarily metabolized by CYP3A. The pres...
<p>Confluent Caco-2 cells were incubated for 24 hrs with 0, 4, 8, 12 and 24 µg of toxin B in the pre...
Hepatocellular accumulation of bile acids due to inhibition of the canalicular bile salt export pump...
Tolvaptan is a selective V2-receptor antagonist primarily metabolized by CYP 3A. The present study i...
<p>MiaPaCa-2 and SOJ-6 cells were incubated 1h with drugs affecting lipid metabolism at the indicate...
<p>(a) Cells were incubated with the indicated concentrations of taurocholate for 1 hour. No release...
<p>(A) Dose-response analysis of T-3764518 in HCT-116 cells treated with serial dilutions of T-37645...
<p>(A-D) Inhibitory effects of telmisartan, but not candesartan, on TPA-induced cell proliferation i...